Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 151 results found. Search for [ IPCA ]

Results 60 to 80 of 151
Rupa Burman Roy
April 9, 2020
Since the beginning of the year, both BSE, NSE benchmarks have declined 25%, 24% respectively. Markets will remain closed tomorrow on account of Good Friday.


Anwesha Madhukalya
New Delhi, April 10, 2020
Coronavirus update: After India said that it would help countries in need with Hydroxychloroquine, US President Donald Trump and Brazil President Jair Bolsonaro thanked Prime Minister Narendra Modi


BusinessToday.In
April 9, 2020
The brokerage said it finds a combination of inexpensive valuations and a comparatively better-positioned balance sheet that could enable the bank to recover from this event faster than its peers.


Aseem Thapliyal
April 9, 2020
An investment of Rs 1 lakh in this retail stock on March 24 would have turned to Rs 1.83 lakh now


BusinessToday.In
April 9, 2020
Nasscom has asked the government to bear the provident fund contribution of such employees and companies for the next three months


BusinessToday.In
April 9, 2020
Cipla said that the drug is used for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.


PTI
April 9, 2020
At the interbank foreign exchange the rupee opened at 76.11, registering a rise of 23 paise over its previous close.


BusinessToday.In
April 9, 2020
Ipca Laboratories, Zydus Cadila and Wallace Pharmaceuticals are major pharma firms manufacturing Hydroxychloroquine in India


BusinessToday.In
April 9, 2020
Sensex, Nifty Live News Today: Globally indices turned green as investors turned optimistic over prospects of more government stimulus and tightened lockdowns across the world to combat the virus spread.


E Kumar Sharma
April 9, 2020
New theories on coronavirus's impact on human body are emerging, on the basis of which new solutions and lines of treatment are being examined


Joe C Mathew
April 9, 2020
From a hospital becoming an epicentre of coronavirus outbreak to effective managment of the contagion, Bhilwara has emerged as the example for many states today


BusinessToday.In
April 8, 2020
However, India may see a strong sequential recovery in the second half of the financial year 2020-21, Goldman Sachs said


BusinessToday.In
April 8, 2020
Pradhan wrote on his official Twitter handle, 'We should all try and do our bit for society in these difficult times. Proud of my wife Mridula and daughter Naimisha who are making safety masks for all of us at home, and also for others who need it'.


BusinessToday.In
New Delhi, April 8, 2020
Coronavirus update: The government has said that all suspected and confirmed cases must be kept in separate areas in all facilities, preferably with separate entry and exit


BusinessToday.In
April 8, 2020
Live updates on India coronavirus: Essentials will be delivered door-to-door in sealed coronavirus hotspots in Delhi; list of sealed areas to be released tomorrow


PB Jayakumar | E Kumar Sharma
April 7, 2020
According to some studies, Hydroxychloroquine has shown strong antiviral effects on the coronavirus infection, which prompted US President Donald Trump to seek India's help in procuring the drug


PB Jayakumar
New Delhi, April 5, 2020
Coronavirus update: Over a hundred Indian companies are making or have the capability to produce finished drugs for malaria, but the APIs have to come from China, say sources


Ajita Shashidhar and E Kumar Sharma
New Delhi, April 1, 2020
FMCG, online retail, telecom and pharma seem to be the obvious gainers of the Covid-19 pandemic


BusinessToday.In
New Delhi, March 26, 2020
A global hunt is on to find the right medicine for coronavirus. Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. The demand for hydroxychloroquine and chloroquine jumped after US President Donald Trump called them effective in treating COVID-19. The Indian Council of Medical Research (ICMR) had also recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases. The Indian manufacturers have, however, reassured that there is enough capacity to meet the demand. Watch the video for more.Also Read: Hand sanitiser demand grows 1425%, face-mask 408% in February-March: Nielsen


E Kumar Sharma
New Delhi, March 25, 2020
Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. Cipla and Aurobindo are making anti-HIV medicines


PAGES 4 OF 8  12345